The total return over the past 12 months is -62.89% vs. +16.94% for the S&P 500. So far it's up -61.42% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (62.89%) | (36.88%) | (33.18%) | N/A | N/A | N/A |
| Total Return CAGR | (62.89%) | (36.88%) | (33.18%) | N/A | N/A | N/A |
| Revenue CAGR | N/A | (26.90%) | (31.02%) | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Milestone Pharmaceuticals Inc. (MIST)
| Year | Start price | End price | MIST Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $2.02 | $0.78 | (61.42%) | +14.51% | (75.93%) |
| 2025 | $2.36 | $2.02 | (14.41%) | +17.72% | (32.13%) |
| 2024 | $1.67 | $2.36 | +41.32% | +24.89% | +16.43% |
| 2023 | $3.96 | $1.67 | (57.83%) | +26.19% | (84.02%) |
| 2022 | $6.55 | $3.96 | (39.54%) | (18.17%) | (21.37%) |
| 2021 | $6.70 | $6.55 | (2.24%) | +28.74% | (30.98%) |
| 2020 | $16.01 | $6.70 | (58.15%) | +18.37% | (76.52%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
